Yarbrough Capital’s Idexx Laboratories IDXX Stock Holding History

Yarbrough Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-777	Closed	-$526K	–	114
2025 Q4	$526K	Hold	777	–	–	0.02%	114
2025 Q3	$496K	Hold	777	–	–	0.02%	124
2025 Q2	$417K	Hold	777	–	–	0.01%	135
2025 Q1	$326K	Hold	777	–	–	0.01%	164
2024 Q4	$321K	Hold	777	–	–	0.01%	166
2024 Q3	$393K	Hold	777	–	–	0.02%	156
2024 Q2	$379K	Hold	777	–	–	0.02%	152
2024 Q1	$420K	Hold	777	–	–	0.02%	149
2023 Q4	$431K	Hold	777	–	–	0.02%	151
2023 Q3	$340K	Hold	777	–	–	0.02%	167
2023 Q2	$390K	Hold	777	–	–	0.02%	156
2023 Q1	$389K	Hold	777	–	–	0.03%	149
2022 Q4	$317K	Hold	777	–	–	0.03%	138
2022 Q3	$253K	Hold	777	–	–	0.02%	172
2022 Q2	$273K	Hold	777	–	–	0.02%	157
2022 Q1	$425K	Hold	777	–	–	0.02%	155
2021 Q4	$512K	Buy	+777	New	+$488K	0.03%	141

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Yarbrough Capital's IDXX Position: Q1 2026 in Review

Yarbrough Capital sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 777 shares — an estimated $526K sold.

Yarbrough Capital first reported a position in IDXX in Q4 2021 and held it in 17 quarters. The position peaked at $526K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Yarbrough Capital reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Yarbrough Capital sold 777 Idexx Laboratories shares in Q1 2026, an estimated $526K.
Yarbrough Capital first reported a position in Idexx Laboratories in Q4 2021 and held it in 17 quarters.
Yarbrough Capital's Idexx Laboratories position peaked at $526K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Yarbrough Capital's 13F filing for Q1 2026, filed 14 Apr 2026.